Medtronic (MDT) Stock: Buy, Sell, or Hold?
MDT - Medtronic plc
$90.96
-0.66 (-0.72%)
âŧ
5d:
-2.3%
30d:
+0.22%
90d:
+13.23%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Sep 01, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 2, 2026 at $92.18 · last confirmed Sep 10, 2026
Strength: 7.0/10
Get Alerted When MDT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MDT is fairly priced but lacks strong directional signals. At 0.5% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MDT is fairly priced but lacks strong directional signals. At 0.5% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$124.48
Based on 6.8% avg growth
INTRINSIC VALUE TODAY
$77.29
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MDT is currently trading at $90.96, which is considered fair relative to its 30-day fair value range of $88.51 to $93.11. The stock's valuation (Forward PE: 15.0) is in line with its historical norms (14.8). At these levels, the market is pricing in 0.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MDT is in a strong uptrend. The price is currently testing key support at $89.94. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MDT scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $104.76 (+15.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MDT is in a strong uptrend. The price is currently testing key support at $89.94. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MDT scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $104.76 (+15.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$88.51 -
$93.11
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
48.6%
Protect Your Profits
Holding MDT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (39/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($104.76)
- NEUTRAL: Market pricing in 0.5% annual earnings growth - fairly valued
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$88.51 -
$93.11
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$89.94
Resistance Level
$95.41
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.01
Wall Street Target
$104.76
(+15.2%)
Revenue Growth (YoY)
13.7%
Earnings Growth (YoY)
40.7%
Profit Margin
13.9%
Valuation Premium vs History
+0.5% premium
PE vs Historical
15.0 vs 14.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.5%
(market-implied from PE analysis)
1-Year Target
$91.41
(+1%)
2-Year Target
$91.87
(+1%)
3-Year Target
$92.33
(+2%)
3-Yr Target (if PE normalizes)
(PE: 15â15)
PE COMPRESSION
$91.01
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 9.6%)
$160.76
(+77%)
Base:
(SPY PE: 15.0, Growth: 9.6%)
$119.66
(+32%)
Bear:
(PE: 12.8, Growth: 9.6%)
$101.71
(+12%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (23x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 22.62 | Current EPS (TTM): $4.05
Bull Case
$150.76
(+66%)
Analyst growth 49.6%, PE expands to 24.9
Base Case
$137.05
(+51%)
Market implied 49.6%, PE stable at 22.6
Bear Case
$62.30
(-32%)
Severe decline -20.0%, PE contracts to 19.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 12, 2026 6:40 AM ET
Data refreshes hourly during market hours. Next update: 7:40 AM
Data refreshes hourly during market hours. Next update: 7:40 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MDT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Ro Khanna
SELL
2026-03-23
Kevin Hern
SELL
2026-03-20
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 41 HOLD |
Advanced MDT Option Strategies
Professional options setups generated by AI based on today's MDT price and gamma walls.
